sufentanil citrate
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
7 FDA-registered drug labelers
Bond Pharmacy INC
Hospira, Inc.
Medisca Inc.
Pharma Source Direct, Inc.
Professional Compounding Centers of America dba PCCA
SpecGx LLC
Veranova, L.P.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Sufentanil Citrate
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Sufentanil Citrate Injection
05/03/2022Unavailable
current
Sufentanil Citrate Injection
05/03/2022Available
Chemical Identity
CAS60561-17-3
PubChem CID65494
DTXSIDDTXSID5048928
FormulaC28H38N2O9S
Mol. Weight578.7 g/mol
SMILESCCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
Data Sources
654942026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/sufentanil citrate/cids/JSON
Archive: data/sources/pubchem_name/sufentanil citrate.json
CAS 60561-17-32026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 60561-17-32026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json